Versican Plus Pi

RSS

Authorised

This medicine is authorised for use in the European Union

canine parainfluenza virus
MedicineVeterinaryAuthorised

Icelandic is available via eTranslation, the European Commission's machine translation service.

Translate to Icelandic | Important information about machine translation

  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

български (BG) (93.36 KB - PDF)

Skoða

español (ES) (81.97 KB - PDF)

Skoða

čeština (CS) (93.99 KB - PDF)

Skoða

dansk (DA) (83.34 KB - PDF)

Skoða

Deutsch (DE) (82.76 KB - PDF)

Skoða

eesti (ET) (82.18 KB - PDF)

Skoða

ελληνικά (EL) (93.76 KB - PDF)

Skoða

français (FR) (82.44 KB - PDF)

Skoða

Gaeilge (GA) (83.57 KB - PDF)

Skoða

hrvatski (HR) (92.27 KB - PDF)

Skoða

italiano (IT) (82.29 KB - PDF)

Skoða

latviešu (LV) (94.29 KB - PDF)

Skoða

lietuvių (LT) (94.03 KB - PDF)

Skoða

magyar (HU) (94.15 KB - PDF)

Skoða

Malti (MT) (95.95 KB - PDF)

Skoða

Nederlands (NL) (82.05 KB - PDF)

Skoða

polski (PL) (95.62 KB - PDF)

Skoða

português (PT) (83.01 KB - PDF)

Skoða

română (RO) (94.17 KB - PDF)

Skoða

slovenčina (SK) (94.08 KB - PDF)

Skoða

slovenščina (SL) (82.27 KB - PDF)

Skoða

suomi (FI) (81.54 KB - PDF)

Skoða

svenska (SV) (82.05 KB - PDF)

Skoða

Íslenska (IS) (83.29 KB - PDF)

Skoða

norsk (NO) (82 KB - PDF)

Skoða

Product information

български (BG) (91.78 KB - PDF)

Skoða

español (ES) (81.51 KB - PDF)

Skoða

čeština (CS) (92.48 KB - PDF)

Skoða

dansk (DA) (82.05 KB - PDF)

Skoða

Deutsch (DE) (81.72 KB - PDF)

Skoða

eesti (ET) (81.22 KB - PDF)

Skoða

ελληνικά (EL) (91.79 KB - PDF)

Skoða

français (FR) (81.63 KB - PDF)

Skoða

Gaeilge (GA) (81.36 KB - PDF)

Skoða

hrvatski (HR) (91.56 KB - PDF)

Skoða

italiano (IT) (81.76 KB - PDF)

Skoða

latviešu (LV) (92.14 KB - PDF)

Skoða

lietuvių (LT) (92.19 KB - PDF)

Skoða

magyar (HU) (92.76 KB - PDF)

Skoða

Malti (MT) (93.86 KB - PDF)

Skoða

Nederlands (NL) (81.15 KB - PDF)

Skoða

polski (PL) (93.22 KB - PDF)

Skoða

português (PT) (82.53 KB - PDF)

Skoða

română (RO) (91.73 KB - PDF)

Skoða

slovenčina (SK) (81.75 KB - PDF)

Skoða

slovenščina (SL) (81.76 KB - PDF)

Skoða

suomi (FI) (81.11 KB - PDF)

Skoða

svenska (SV) (81.47 KB - PDF)

Skoða

Íslenska (IS) (81.52 KB - PDF)

Skoða

norsk (NO) (81.52 KB - PDF)

Skoða
Latest procedure affecting product information:IB/0012

български (BG) (93.36 KB - PDF)

Skoða

español (ES) (81.97 KB - PDF)

Skoða

čeština (CS) (93.99 KB - PDF)

Skoða

dansk (DA) (83.34 KB - PDF)

Skoða

Deutsch (DE) (82.76 KB - PDF)

Skoða

eesti (ET) (82.18 KB - PDF)

Skoða

ελληνικά (EL) (93.76 KB - PDF)

Skoða

français (FR) (82.44 KB - PDF)

Skoða

Gaeilge (GA) (83.57 KB - PDF)

Skoða

hrvatski (HR) (92.27 KB - PDF)

Skoða

italiano (IT) (82.29 KB - PDF)

Skoða

latviešu (LV) (94.29 KB - PDF)

Skoða

lietuvių (LT) (94.03 KB - PDF)

Skoða

magyar (HU) (94.15 KB - PDF)

Skoða

Malti (MT) (95.95 KB - PDF)

Skoða

Nederlands (NL) (82.05 KB - PDF)

Skoða

polski (PL) (95.62 KB - PDF)

Skoða

português (PT) (83.01 KB - PDF)

Skoða

română (RO) (94.17 KB - PDF)

Skoða

slovenčina (SK) (94.08 KB - PDF)

Skoða

slovenščina (SL) (82.27 KB - PDF)

Skoða

suomi (FI) (81.54 KB - PDF)

Skoða

svenska (SV) (82.05 KB - PDF)

Skoða

Íslenska (IS) (83.29 KB - PDF)

Skoða

norsk (NO) (82 KB - PDF)

Skoða

Product details

Name of medicine
Versican Plus Pi
Active substance
canine parainfluenza type-2 virus, strain CPiV-2 Bio 15 (live attenuated)
International non-proprietary name (INN) or common name
canine parainfluenza virus

Authorisation details

EMA product number
EMEA/V/C/003681

Assessment history

This page was last updated on

Share this page